| Description | Glibornuride is a blocker of ATP-sensitive K+ channel(pKi: 5.75). Glibornuride inhibits high affinity [3H]-glibenclamide binding with the potencies expected from their K+ channel activity. |
| In vivo | Glibornuride（5 mg/kg；灌胃，每天一次，持续28天）可明显增加瑞士白鼠糖尿病组的体重。连续使用Glibornuride 28天，显著提高了糖尿病大鼠的肝脏脂质过氧化水平。Glibornuride治疗（28天）能降低糖尿病大鼠的血清尿酸水平[2]。 |
| Target activity | K+-ATP channel:5.75 (pKi) |
| molecular weight | 366.48 |
| Molecular formula | C18H26N2O4S |
| CAS | 26944-48-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 250 mg/mL (682.17 mM) |
| References | 1. Löffler C, et al. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta. Br J Pharmacol. 1997 Feb;120(3):476-80. 2. Ozsoy-Sacan O, et al. Effects of parsley (Petroselinum crispum) extract versus Glibornuride on the liver of streptozotocin-induced diabetic rats. J Ethnopharmacol. 2006 Mar 8;104(1-2):175-81. |